Linzess Targets Chronic Constipation
[caption id="attachment_254" align="alignleft" width="150"] logo created by RKL[/caption] Linzess targets chronic constipation related to long term conditions of undetermined cause such as the Irritable Bowel Syndrome. By definition this requires fewer than 3 bowel movements each week for at least 3 months. Unfortunately this very expensive drug, whose price continues to steadily increase, provides only mild relief. With a cash price in excess of $15 a day, the drug seems as likely to cause harm as benefit. Approximately 1 in 5 individuals receiving Linzess experience diarrhea which at times may be quite serious. Especially among the more fragile this may lead to dehydration, low blood pressure, dizziness and possibly fainting episodes. Advertisements aimed at the general public suggest the drug offers major advances in combating constipation. Studies however suggest Linzess…